New Lung Cancer Treatment
Metformin Appears To Fight Lung Cancer But Only In Overweight Patients
Metformin is a common drug prescribed for patients with Type 2 patients to lower their blood sugar. It is a FDA approved drug since 1995 and is used by about [...]
FDA Approves New Drug for Lung Cancer
Lung cancer is one of the leading causes behind cancer related deaths. Various studies and research works are going on to help lung cancer patients to get cure [...]
Tarlatamab for Small Cell Lung Cancer
Lung cancer is the second most form of cancers and remains the leading cause of cancer deaths. A variety of new treatments are helping to bring down the number [...]
World’s First Lung Cancer Vaccine Trials Launched Across Seven Countries
Lung cancer is the leading cause of cancer deaths all across the world. It accounts for about 1.8m deaths every year.
Doctors have begun trailing the [...]
Osimertinib Plus Chemo Approved as Ist-Line Treatment for Patients with Lung Cancer
Lung cancer is the leading cause of cancer deaths among both men and women. It broadly splits into NSCLC and small cell lung cancer.
Osimertinib (Tagrisso) in [...]
Researchers Find How Precision Radiation Therapy Supports In Lung Cancer Treatment
A recent study has been conducted by the researchers at The University of Texas MD Anderson Cancer Centre and the results of which were published in JAMA [...]
Roche’s Genentech Gets FDA Approval for Lung Cancer Treatment
Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of [...]
World’s First Lung Cancer Vaccine is Being Developed by UK Researchers
Lung cancer is the deadliest form of cancers all around the world including Britain. Every year, around 50,000 cases and 35,000 deaths of patients with lung [...]
New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients [...]
Targeted Therapy Better than Immunotherapy in Some Patients with NSCLC
Non-small cell lung cancer continues to remain one of the main reasons behind cancer related deaths all across the world. Continuous studies and research works [...]
SABR For Inoperable Early Stage NSCLC
Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is [...]
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy [...]